A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

标题
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume 10, Issue 12, Pages e9172
出版商
EMBO
发表日期
2018-10-30
DOI
10.15252/emmm.201809172

向作者/读者发起求助以获取更多资源

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started